Description
ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Abraxane is classified as an “plant alkaloid,” a “taxane” and an “antimicrotubule agent.
Manufacturer: Biocon India